Preview

Extreme Medicine

Advanced search

Efficacy of fabomotizole in counteracting the sequelae of prenatal peat smoke exposure in rats: Application of WOE/IV methodology

https://doi.org/10.47183/mes.2026-545

Abstract

Introduction. Peat fire smoke poses a significant threat to public health by degrading ambient air quality. Pregnant women and the developing fetus represent the most vulnerable population subgroup due to heightened susceptibility to toxicants. The use of fabomotizole — a selective anxiolytic agent — is of particular interest for mitigating these pathological outcomes. Traditional preclinical statistical approaches often fail to provide a comprehensive quantitative benefit-risk assessment. The integration of advanced mathematical tools — specifically, the weight of evidence (WoE) and information value (IV) methodologies developed by the Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP), Russia — enables objective prediction of drug efficacy. This approach establishes a methodologically advanced framework for evidence-based decision-making in pharmaceutical R&D.

Objective. To assess the embryotoxicity and neurotoxic effects of peat smoke exposure in a rat model, and to evaluate the corrective efficacy of fabomotizole using WoE and IV methodologies.

Materials and methods. The study utilized outbred female Wistar rats (n = 10–14) weighing 240–270 g. To model smoke-induced teratogenesis, pregnant females were subjected to daily inhalational exposure of peat smoke from gestational day (GD) 1 to GD 20 (exposure duration: 44 min/day). Exposures were conducted during the critical window of organogenesis. Pharmacological correction was administered via oral gavage. Pregnant females received fabomotizole prenatally at doses of 1 and 10 mg/kg/day. Postnatal offspring were exposed to the compound through lactation at an estimated dose of 1–10 mg/kg/day. On postnatal day (PND) 21, direct administration was initiated at a dosage of 200 mg/kg/day. Embryotoxicity was assessed via gross necropsy and visceral examination. Postnatal development was evaluated using the following endpoints: sensorimotor reflex maturation (righting reflex), grip strength, locomotor activity, anxiety-like behavior, and cognitive function. Statistical analysis was performed using Statistica 10.0 and IBM SPSS Statistics 22.

Results. Prenatal exposure to peat smoke resulted in a significant increase in the incidence of developmental abnormalities. Specifically, hyperemia rates rose from 10.6% to 58.5%, petechiae increased from 7.1% to 43.1%, and intra-abdominal hemorrhage surged from 7.8% to 84.3%. Skeletal malformations included renal ectopia (rising from 12.5% to 27.1%) and delayed ossification: notably, retardation of the occipital bone was observed in 58.5% of specimens, with complete absence in 20.8%. In the offspring cohort, delayed acquisition of the cliff aversion reflex was observed in 65% of males and 59% of females, accompanied by increased anxiety-like behavior and cognitive impairment. Fabomotizole treatment (1 and 10 mg/kg) significantly reduced the incidence of developmental anomalies (p < 0.05), promoted skeletal ossification (most pronounced at 1 mg/kg), and normalized sensorimotor reflexes and behavioral performance. The calculated WoE index was 1.46 for the 1 mg/kg dose and 1.20 for the 10 mg/kg dose (p < 0.05), indicating strong predictive validity.

Conclusions. WoE and IV methodologies demonstrated a corrective effect of fabomotizole. The calculated WoE indices were 1.46 for the 1 mg/kg dose and 1.20 for the 10 mg/kg dose (p < 0.05). IV analysis identified hyperemia and hemorrhagic lesions as the primary predictors of embryotoxicity (IV = 0.34, p < 0.05). Skeletal malformations, including delayed ossification, also contributed significantly to the model (IV = 0.11). The consistency between WoE/IV metrics and classical statistical methods underscores the translational potential of this approach for preclinical drug safety assessment.

About the Authors

D. M. Ivashova
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Moscow



O. V. Shreder
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation

Moscow



References

1. Dobrykh VA, Zakharycheva TA. Forest fire smoke and health. Khabarovsk: DVGMU; 2009 (In Russ.). EDN: QISIOP

2. Gladkikh VD, Ivanov MB, Alekhnovich AV, Barinov VA, Balandin NV, Vershinina GV, et al. Toxicology of combustion products. Clinical and experimental aspects. Moscow: Kommentariy; 2020 (In Russ.). EDN: OLWPPG

3. Shah PS, Balkhair T. Air pollution and birth outcomes: A systematic review. Environment International. 2011;37(2):498–516. https://doi.org/10.1016/j.envint.2010.10.009

4. Choi H, Wang L, Lin X, Spengler JD, Perera FP. Fetal window of vulnerability to airborne polycyclic aromatic hydrocarbons on proportional intrauterine growth restriction. PLOS One. 2012;7(4):e35464. https://doi.org/10.1371/journal.pone.0035464

5. Basilio E, Chen R, Fernandez AC, Padula AM, Robinson JF, Gaw SL. Wildfire smoke exposure during pregnancy: A review of potential mechanisms of placental toxicity, impact on obstetric outcomes, and strategies to reduce exposure. International Journal of Environmental Research and Public Health. 2022;19(21):13727. https://doi.org/10.3390/ijerph192113727

6. Gorbatova DM, Nemova EP, Solomina AS, Durnev AD. Prenatal effects of peat combustion products and afobazole correction thereof in the rat progeny. Bulletin of Experimental Biology and Medicine. 2014;158(11):604–8 (In Russ.). EDN: TEWYEB

7. Ivashova DM, Litvinova SA, Voronina TA, Tsorin IB. Effects of prenatal exposure to peat smoke on the emotional behavior of rat offspring and its correction with fabomotizole. Medical Academic Journal. 2021;21(1):47–58 (In Russ.). https://doi.org/10.17816/MAJ60528

8. Gorbatova DM, Nemova EP, Solomina AS, Durnev AD. DNA damage in placenta and embryos of rats exposed to peat smoke; antigenotoxic effects of afobazole. Bulletin of Experimental Biology and Medicine. 2014;158(11):50–6 (In Russ.). https://doi.org/10.17816/ecogen14250-56

9. Sosedova LM, Vokina VA, Titov EA, Novikov MA, Tyutrina VA. Assessment of the safety of short-term exposure of peat thermal degradation products in sublethal concentrations on rats. Toxicological Review. 2025;33(1):5–16 (In Russ.). https://doi.org/10.47470/0869-7922-2025-33-1-5-16

10. Sosedova LM, Vokina VA, Novikov MA, Andreeva ES, Alekseenko AN, Zhurba OM, et al. Reproductive function of male rats and motor activity of their offspring in fire emissions modeling. Bulletin of Experimental Biology and Medicine. 2021;172(10):488–94 (In Russ.). https://doi.org/10.47056/0365-9615-2021-172-10-488-494

11. Sosedova LM, Vokina VA, Pankova AA, Rukavishnikov VS. Reproductive toxicity of wildfire smoke. Bulletin of Experimental Biology and Medicine. 2026;180(4):463–9 (In Russ.). https://doi.org/10.1007/s10517-026-06658-1

12. Pankova AA, Vokina VA, Sosedova LM, Rukavishnikov VS. Peat smoke exposure as a risk factor for deterioration of postnatal development. Hygiene and Sanitation. 2024;103(9):1044–9 (In Russ.). https://doi.org/10.47470/0016-9900-2024-103-9-1044-1049

13. Vokina VA, Sosedova LM, Novikov MA, Titov EA, Andreeva ES, Rukavishnikov VS. Effects of daily peat smoke exposure on present and next generations. Toxics. 2022;10(12):750. https://doi.org/10.3390/toxics10120750

14. Shreder OV, Bunyatyan ND, Goryachev DV, Subaev RD, Engalycheva GN, Kuznetsova AD, et al. Mathematical prediction of drug efficacy in preclinical studies. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2022;12(3):315–30 (In Russ.). https://doi.org/10.30895/1991-2919-2022-12-3-315-330

15. Vanslette K, Tohme T, Youcef-Toumi K. A general model validation and testing tool. Reliability Engineering & System Safety. 2020;195:106684. https://doi.org/10.1016/j.res.2019.106684

16. Ivashova DM, Shreder OV, Goryachev DV. Validating preclinical assessment of a medicine benefit-risk ratio based on WOE and IV models. Safety and Risk of Pharmacotherapy. 2025;13(4):440–51 (In Russ.). https://doi.org/10.30895/2312-7821-2025-13-4-440-451

17. Zeng G. A necessary condition for a good binning algorithm in credit scoring. Applied Mathematical Sciences. 2014;8(65):3229–42. https://doi.org/10.12988/ams.2014.44300

18. Mortamais M, Pujol J, van Drooge BL, Macia D, Martinez-Vilavella G, Reynes C, et al. Effect of exposure to polycyclic aromatic hydrocarbons on basal ganglia and attention-deficit hyperactivity disorder symptoms in primary school children. Environment International. 2017;105:12–9. https://doi.org/10.1016/j.envint.2017.04.011

19. Otellin VA, Khozhay LI, Ordian NE. Prenatal stressful influences and the developing brain. adaptive mechanisms, immediate and delayed effects. St. Petersburg: Desyatka; 2007.

20. Dubrovskaya NM, Vasilev DS, Tumanova NL, Alekseeva OS, Nalivaeva NN. Prenatal hypoxia impairs olfactory function in postnatal ontogenesis of rats. I.P. Pavlov Journal of Higher Nervous Activity. 2021;71(3):415–27 (In Russ.). https://doi.org/10.31857/S0044467721030035

21. Wang B, Zeng H, Liu J, Sun M. Effects of prenatal hypoxia on nervous system development and related diseases. Frontiers in Neuroscience. 2021;15:755554. https://doi.org/10.3389/fnins.2021.755554

22. Mirzoyan RS, Balasanyan MG, Topchyan HV, Hakobyan VP, Gan’shina TS, Khaylov NS, et al. The cerebrovascular, neuroprotective and antiarrhythmic properties of the anxiolytic fabomotizole. Annals of Clinical and Experimental Neurology. 2022;16(3):65–73 (In Russ.). https://doi.org/10.54101/ACEN.2022.3.8

23. Voronin MV, Vakhitova YuV, Tsypysheva IP, Tsypyshev DO, Rybina IV, Kurbanov RD, et al. Involvement of Chaperone Sigma1R in the anxiolytic effect of fabomotizole. International Journal of Molecular Sciences. 2021;22:5455. https://doi.org/10.3390/ijms22115455

24. Buneeva OA, Kapitsa IG, Zavyalova MG, Kaloshina SA, Zgoda VG, Medvedev AE. Delayed effect of the neuroprotector fabomotizole on the rat brain proteome in the rotenone model of parkinsonism. Biomedical Chemistry. 2025;71(3):217–26 (In Russ.). https://doi.org/10.18097/PBMCR1586

25. McCallister MM, Li Z, Zhang T, Ramesh A, Clark RS, Maguire M, et al. Revealing behavioral learning deficit phenotypes subsequent to in utero exposure to benzo(a)pyrene. Toxicological Sciences. 2016;149(1):42–54. https://doi.org/10.1093/toxsci/kfv212

26. Patel B, Das SK, Patri M. Neonatal benzo[a]pyrene exposure induces oxidative stress and DNA damage causing neurobehavioural changes during the early adolescence period in rats. Developmental Neuroscience. 2016;38(2):150–62. https://doi.org/10.1159/000446276

27. Das L, Patel B, Patri M. Adolescence benzo[a]pyrene treatment induces learning and memory impairment and anxiolytic like behavioral response altering neuronal morphology of hippocampus in adult male Wistar rats. Toxicology Reports. 2019;6:1104–13. https://doi.org/10.1016/j.toxrep.2019.10.014

28. Jee SC, Kim M, Kim KS, Kim HS, Sung JS. Protective effects of myricetin on benzo[a]pyrene-induced 8-hydroxy-2’-deoxyguanosine and BPDE-DNA adduct. Antioxidants. 2020;9(5):446. https://doi.org/10.3390/antiox9050446

29. Stoddard EG, Killinger BJ, Nag SA, Martin J, Corley R, Smith JN, et al. Benzo[a]pyrene induction of glutathione s-transferases: an activity-based protein profiling investigation. Chemical Research in Toxicology. 2019;32(6):1259–67. https://doi.org/10.1021/acs.chemrestox.9b00069

30. Nalivaeva NN, Turner AJ, Zhuravin IA. Role of prenatal hypoxia in brain development, cognitive functions, and neurodegeneration. Frontiers in Neuroscience. 2018;12:825. https://doi.org/10.3389/fnins.2018.00825

31. Stratilov V, Potapova S, Safarova D, Tyulkova E, Vetrovoy O. Prenatal hypoxia triggers a glucocorticoid-associated depressive-like phenotype in adult rats, accompanied by reduced anxiety in response to stress. International Journal of Molecular Sciences. 2024;25(11):5756 https://doi.org/10.3390/ijms25115902


Review

For citations:


Ivashova D.M., Shreder O.V. Efficacy of fabomotizole in counteracting the sequelae of prenatal peat smoke exposure in rats: Application of WOE/IV methodology. Extreme Medicine. (In Russ.) https://doi.org/10.47183/mes.2026-545

Views: 35

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3033-8964 (Print)
ISSN 3033-8972 (Online)